Navigation Links
Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report
Date:5/4/2011

nt, while the Medical Device industry's share increased to 43 percent.  Compared with the first quarter of 2010, the investment split remained unchanged.

For all sectors, venture capitalists invested $5.9 billion in 736 deals in Q1 2011, a 14 percent increase in dollars and an 6 percent decrease in deals, compared to $5.2 billion going into 787 deals in Q1 2010.  The Life Sciences share of total venture capital dollars invested slipped slightly to 24 percent in the first quarter of 2011 from 25 percent in the first quarter of 2010.

In Q1 2011, Biotechnology investing grew by 5 percent in dollars but dropped 21 percent in deals year over year with $784 million going into 85 deals. Medical device investments increased 9 percent in dollars and 11 percent in deals in Q1 2011, compared to the same quarter a year ago.  With $602 million going into 79 deals, the Medical Device industry ranked behind Software, Industrial/Energy, and Biotechnology in dollars invested.

First-Time Financing

During the first quarter of 2011, 35 Life Sciences companies received venture capital funding for the first time, capturing $129 million.  This represents a sharp decline of 40 percent in the number of companies and a 46 percent drop in dollars invested compared to the first quarter of 2010.  First-time deals in the Life Sciences sector averaged $3.7 million in the first quarter of 2011, compared with an average deal size of $6.1 million in the first quarter of 2010.

"First-time funding is expected to remain challenging for the sector, with fewer deals and smaller deal size for fledgling companies," Lefteroff observed. "Lengthy and costly R&D and uncertainty in the regulatory approval process continue to drive more investors toward follow-on and later-stage deals with companies that are closer to successful product launches or the exit market," he continu
'/>"/>

SOURCE PwC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. California Academy of Sciences launches scientific expedition to the Philippines
2. Scientists explore ways to restore health energy balance at the New York Academy of Sciences
3. Jean Y.J. Wang elected to the American Academy of Arts & Sciences
4. UC Riverside biologist elected to American Academy of Arts and Sciences
5. Stanford professor honored for contributions to computational biosciences
6. Springer launches Journal of Environmental Studies and Sciences
7. Tufts professor earns ISCB Award for Excellence in Chemical Sciences
8. UM College of Arts and Sciences student is awarded AACR-Thomas J. Bardos Science Education Award
9. Louisiana Tech University professor named a 2011 Environmental Health Sciences Fellow
10. UC Riverside geneticist elected home secretary of the National Academy of Sciences
11. Challenges for biofuels: New life cycle assessment report from Energy Biosciences Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of ... report to their offering. One ... adoption of multimodal biometric systems. Multimodal biometric systems ... for verification and identification purposes. This helps to ...
(Date:12/10/2014)... 8, 2014 You,ve been here before: you desperately ... remember your password, site key or the answer to your ... grade teacher? Today, Hoyos Labs , ... that will finally put an end to the frustration that ... . 1U leverages a user,s smartphone to acquire his ...
(Date:12/10/2014)... -- CIE San Diego has launched an innovative trust ... that enhances care coordination among social service and care ... earned a second $1 million grant from the Alliance ... in community and; will be recognized as a "Live ... 4-6p. CIE San Diego today announced the ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... for Agricultural Research and Development, and the company FARMARABA ... produce Omega 3 using marine plant micro-organisms. The ultimate ... highly valued fatty acid, and then apply them at ... centre, which has proven experience in the biotechnology and ...
... Children living near toxic waste sites in ... Indonesia may experience higher blood lead levels, resulting in a ... retardation, according to a study presented today by Kevin Chatham-Stephens, ... Medicine at Mount Sinai, at the Pediatric Academic Societies (PAS) ...
... than two million people in the United States suffer ... abnormal nerve cell firing in the brain which often ... therapies reduce seizures in about two-thirds of patients, the ... therapy and those who take drugs can experience harmful ...
Cached Biology News:Neiker-Tecnalia and FARMARABA produce Omega 3 using marine plant micro-organisms 2Children living near toxic waste sites experience higher blood lead levels resulting in lower IQ 2
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... VANCOUVER , Dec. 22, 2014 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development of ... paper out of the University of Calgary in conjunction ... North Carolina, which further validates the company,s ongoing clinical ... the effects of pattern baldness. The paper ...
(Date:12/22/2014)... December 22, 2014 ITRA Global, one ... occupiers of commercial real estate, has further expanded its ... in Perth and Brisbane, Western Australia, reports Mylinda Vick, ... , ITRA Global / ACORPP (Australian Corporate Property ... consultancy company providing property services to a wide range ...
(Date:12/19/2014)... 19, 2014 Naurex Inc., a biopharmaceutical company ... diseases of the central nervous system, today announced that ... officer, will present at the 33 rd annual ... place at 3:00 p.m. PST on Tuesday, January 13, ... San Francisco, Calif. About ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2
... 7 Cyberonics, Inc. (Nasdaq: CYBX ) today ... Food and Drug Administration ("FDA") to amend the protocol of ... VNS TherapyTM.Based on a reassessment of the study power and ... data analysis originally specified in the study protocol, the company ...
... Calif., Jan. 7 Codexis, Inc. today announced,a licensing ... publicly-undisclosed generic product, using a proprietary Codexis,biocatalyst. Teva, ... a,leading producer of this generic product. The product ... the United States. , Under ...
... Corporation, a leading,developer of targeted, systemic RNA interference ... the final tranche of its Series B,financing. Astellas ... investor, Lilly Ventures, also participating. The addition ... to $21.4 million. Intradigm will,use Series B ...
Cached Biology Technology:Cyberonics Provides Business Update on Depression Clinical Trial 2Cyberonics Provides Business Update on Depression Clinical Trial 3Codexis, Teva in Licensing Agreement Final 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 2Intradigm Closes Final Tranche of $21.4 Million Series B Financing 3
...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Standard 2" and 3" Fiberboard Boxes can be sold separately or with 16, 25, 36, 49, 64, 81 or 100 cell dividers. Fiberboard boxes can also be ordered with corresponding freezer racks...
Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
Biology Products: